Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.

导出 OA

翻译打印收藏纠错

作者： Gemma,Bruera ^[1] ; Silvia,Massacese ^[2] ; Antonio,Galvano ^[3] ; Antonella Dal,Mas ^[4] ; Stefano,Guadagni ^[5] ; Giuseppe,Calvisi ^[6] ; Eugenio,Ciacco ^[2] ; Antonio,Russo ^[5] ; Enrico,Ricevuto ^[3] ; Oncology Network ASL1 Abruzzo, Italy ^[4]

作者单位： Oncology Territorial Care, S. Salvatore Hospital, Oncology Network ASL1 Abruzzo, University of L'Aquila, L'Aquila, Italy. ^[1] Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. ^[2] Pharmacy Unit, S. Salvatore Hospital, Oncology Network ASL1 Abruzzo, L'Aquila, Italy. ^[3] Medical Oncology, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy. ^[4] Pathology, S. Salvatore Hospital, Oncology Network ASL1 Abruzzo, L'Aquila, Italy. ^[5] University General Surgery, S. Salvatore Hospital, Oncology Network ASL1 Abruzzo, University of L'Aquila, L'Aquila, Italy. ^[6]

关键词 FD/FOx intensive regimen docetaxel, 5-fluorouracil, and oxaliplatin dose-finding study first-line triplet chemotherapy metastatic gastric cancer

DOI 10.18632/oncotarget.24861

PMID 29755655

发布时间 2024-03-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交